Target Concetration - a patented innovation
IST Innuscreen GmbH adds a new and patented technology to its portfolio.
The new technology not only allows for simple and fast target concentration of biomolecules but is also combinable with manual or automated nucleic acid extraction.
TCT allows for large volume samples processing without centrifugation or filter steps. The technology can be combined with DNA or RNA exptraction, ELISA, immunology, flow cytometry and others.